Mark Hiram Gotfried MD

Pulmonology•Phoenix, AZ

Critical Care Medicine, Interstitial Lung Diseases, Sleep Medicine

Physician

Join to View Full Profile

3811 E Bell RdSte 107Phoenix, AZ 85032
Phone+1 602-340-1689
Fax+1 602-340-1853

Education & Training

University of Arizona College of Medicine-TucsonFellowship, Pulmonary Disease and Critical Care Medicine, 1981 - 1983
Michael Reese Hospital and Medical CenterResidency, Internal Medicine, 1977 - 1980
University of Illinois College of MedicineClass of 1977

Certifications & Licensure

AZ State Medical License 1981 - 2026
CA State Medical License 1983 - 2024
IL State Medical License 1978 - 1987
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Pulmonary Disease
National Board of Physicians and Surgeons Internal Medicine
National Board of Physicians and Surgeons Pulmonary Disease
National Board of Physicians and Surgeons Sleep Medicine

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012

Clinical Trials

Intrapulmonary Pharmacokinetics of Antibiotics Start of enrollment: 2006 Jan 01
Terminated
Phase 4
US 10 mL Biologic Lung Volume Reduction (BLVR) Phase 2 Emphysema Study Start of enrollment: 2007 Feb 01
Completed
Phase 2
US Biologic Lung Volume Reduction (BLVR) Phase 2 Emphysema Study Start of enrollment: 2007 Aug 01
Completed
Phase 2
Biologic Lung Volume Reduction (BLVR) Phase 2 Homogeneous Study Start of enrollment: 2008 Feb 01
Completed
Phase 2
Doripenem Intrapulmonary Pharmacokinetics in Healthy Adult Subjects Start of enrollment: 2009 Jun 01
Completed
Phase 1
Comparison Study of the ICON™ CPAP Series With and Without SensAwake™ Start of enrollment: 2013 Mar 01
Completed
Not Applicable
Evaluating the Plasma, Epithelial Lining, and Alveolar Macrophage Concentrations of Intravenous Carbavance™ (RPX2014/RPX7009) in Healthy Adult Subjects Start of enrollment: 2014 Feb 01
Completed
Phase 1
CPAP (Continuous Positive Airway Pressure) Study Educational Materials and Usage Feedback to Promote CPAP Adherence Start of enrollment: 2014 Jan 01
Completed
Not Applicable
Study to Determine and Compare Plasma and Intrapulmonary Pharmacokinetics of WCK 2349 in Healthy Adult Human Subjects Start of enrollment: 2014 Sep 01
Completed
Phase 1
Formoterol Dose Ranging Study (ACHIEVE Duaklir USA Phase IIb) Start of enrollment: 2016 Jun 30
Completed
Phase 2
Trial of AD036 in Obstructive Sleep Apnea Start of enrollment: 2019 Mar 07
Completed
Phase 2
Study of Trans Sodium Crocetinate in Patients With Interstitial Lung Disease Start of enrollment: 2021 Dec 02
Terminated
Phase 2
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

Intrapulmonary pharmacokinetics of SPR719 following oral administration of SPR720 to healthy volunteers.
Keith A Rodvold, Mark H Gotfried, Xilla T Ussery, Shekman L Wong, Kamal A Hamed
Antimicrobial Agents and Chemotherapy. 2024-11-06
1 citations
Efficacy and safety of insomnia treatment with lemborexant in older adults: analyses from three clinical trials.
Mark H Gotfried, Sanford H Auerbach, Thien Thanh Dang-Vu, Kazuo Mishima, Dinesh Kumar
Drugs & Aging. 2024-09-01
4 citations
Plasma and Intrapulmonary Concentrations of Tebipenem following Oral Administration of Tebipenem Pivoxil Hydrobromide to Healthy Adult Subjects.
Keith A Rodvold, Mark H Gotfried, Vipul Gupta, Amanda Ek, Praveen Srivastava
Antimicrobial Agents and Chemotherapy. 2022-07-19